2010
DOI: 10.1186/1471-2202-11-74
|View full text |Cite
|
Sign up to set email alerts
|

GT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neurons

Abstract: BackgroundGangliosides, sialic acid-containing glycosphingolipids exist in mammalian cell membranes particularly neuronal membranes. The trisialoganglioside (GT1b) is one of the major brain gangliosides and acts as an endogenous regulator in the brain. We previously showed GT1b induces mesencephalic dopaminergic (DA) neuronal death, both in vivo and in vitro. We further investigate the underlying mechanisms of GT1b neurotoxicity.ResultsConsistent with earlier findings, GT1b attenuated the DA neuron number and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 50 publications
0
6
0
Order By: Relevance
“…Microglial activation was subsequently shown to be mediated by protein kinase C and NADPH oxidase ( Min et al, 2004 ). Ganglioside GT1b has also been found to be neurotoxic to dopaminergic neurons in vitro ( Chung et al, 2001 ) through a modulation of the Akt/GSK-3/Tau signaling pathway ( Chung et al, 2010 ). In vivo , injection of GT1b into the substantia nigra resulted in the death of nigral neurons, a finding associated with activation of microglia ( Ryu et al, 2002 ).…”
Section: Discussionmentioning
confidence: 99%
“…Microglial activation was subsequently shown to be mediated by protein kinase C and NADPH oxidase ( Min et al, 2004 ). Ganglioside GT1b has also been found to be neurotoxic to dopaminergic neurons in vitro ( Chung et al, 2001 ) through a modulation of the Akt/GSK-3/Tau signaling pathway ( Chung et al, 2010 ). In vivo , injection of GT1b into the substantia nigra resulted in the death of nigral neurons, a finding associated with activation of microglia ( Ryu et al, 2002 ).…”
Section: Discussionmentioning
confidence: 99%
“…There has also been concern that the tumor cells upregulate ABC protein expression in response to therapy, resulting in higher expression during therapy or at recurrence [ 60 , 85 - 87 ] . Germline or somatic polymorphisms of these proteins have also been associated with increased activity, decreased drug exposure, and worse survival in a number of pediatric cancers [ 74 , 88 - 91 ] ; polymorphisms have also been identified as a risk factor for cancer diagnosis [ 90 , 92 - 94 ] , suggesting there may be other functions of these proteins, as we discuss below. Prior studies generally evaluated expression and polymorphisms of the ABC genes proteins in low- or medium-throughput, however, and there is no clear pattern as to which of the 48 proteins may be expressed in a given tumor.…”
Section: Cellular Mechanisms Of Therapeutic Resistance and Counterstr...mentioning
confidence: 99%
“…The tau protein is a phosphoprotein that potentially has 80 serine/threonine and 5 tyrosine phosphorylation sites (15). Phosphorylation of tau was shown to be regulated by kinases, such as GSK-3β and Akt (15,16). To determine whether selenite treatment is accompanied by downregulation of the activity of these kinases, the phosphorylation level of GSK-3β and Akt was measured.…”
Section: Effects Of Selenite Treatment On Gsk-3β and Akt Phosphorylatmentioning
confidence: 99%